Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis, Multidrug-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07167823
What this trial is testing

The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront

Who this might be right for
Pleural EmpyemaTuberculosis (TB)Bacterial Sepsis
University of Health Sciences Lahore 350
Large-scale testing (Phase 3)Study completedNCT02589782
What this trial is testing

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Who this might be right for
Tuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary
Medecins Sans Frontieres, Netherlands 552
Not applicableStudy completedNCT01071603
What this trial is testing

Tuberculosis in China

Who this might be right for
TuberculosisTuberculosis, Multidrug-ResistantExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 199
Not applicableUnknownNCT03409315
What this trial is testing

Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis, Multidrug-Resistant
University Medical Center Groningen 360
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Large-scale testing (Phase 3)Looking for participantsNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Early research (Phase 1)Study completedNCT02236078
What this trial is testing

Brief Bactericidal Activity of Anti-Tuberculosis Drugs

Who this might be right for
TuberculosisDrug-resistant TuberculosisIsoniazid Resistant Tuberculosis (Disorder)
Centers for Disease Control and Prevention 18
Testing effectiveness (Phase 2)Study completedNCT05007821
What this trial is testing

Linezolid Dosing Strategies in Drug-Resistant TB

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisTuberculosis, Pulmonary
National Institute of Allergy and Infectious Diseases (NIAID) 138
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Large-scale testing (Phase 3)WithdrawnNCT02975570
What this trial is testing

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Who this might be right for
Tuberculosis Multi Drug Resistant Active
Boston University
Large-scale testing (Phase 3)Study completedNCT03896685
What this trial is testing

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisPulmonary Tuberculoses+3 more
Médecins Sans Frontières, France 323
Large-scale testing (Phase 3)UnknownNCT02120638
What this trial is testing

Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 100
Large-scale testing (Phase 3)Study completedNCT02754765
What this trial is testing

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Who this might be right for
Tuberculosis, Multidrug-ResistantInfection, BacterialPulmonary Tuberculoses
Médecins Sans Frontières, France 754
Not applicableLooking for participantsNCT06590428
What this trial is testing

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Who this might be right for
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Albert Einstein College of Medicine 280
Post-approval studies (Phase 4)Study completedNCT03867136
What this trial is testing

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 354
Early research (Phase 1)Study completedNCT05526911
What this trial is testing

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 28
Next Page